AQR Capital Management
INFI

AQR Capital Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

AQR Capital Management’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-47,006
Closed -$161K – 2315
2021
Q3 		$161K Buy
+47,006
New +$145K ﹤0.01% 2168
2015
Q4 		– Sell
-25,018
Closed -$211K – 2327
2015
Q3 		$211K Sell
25,018
-28,364
-53% -$262K ﹤0.01% 2041
2015
Q2 		$585K Buy
53,382
+17,688
+50% +$227K ﹤0.01% 1712
2015
Q1 		$499K Buy
+35,694
New +$546K ﹤0.01% 1704
2013
Q3 		– Sell
-56,098
Closed -$912K – 2553
2013
Q2 		$912K Buy
+56,098
New +$1.74M ﹤0.01% 1619

Other funds holding INFI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AQR Capital Management's INFI Position: Q4 2021 in Review

AQR Capital Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2021, closing a stake of 47,006 shares — an estimated $161K sold.

AQR Capital Management first reported a position in INFI in Q2 2013 and held it in 5 quarters. The position peaked at $912K in Q2 2013. 97 funds tracked by Wall St. Rank hold INFI as of Q4 2021.

  • AQR Capital Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
  • AQR Capital Management sold 47,006 Infinity Pharmaceuticals, Inc. shares in Q4 2021, an estimated $161K.
  • AQR Capital Management first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 5 quarters.
  • AQR Capital Management's Infinity Pharmaceuticals, Inc. position peaked at $912K in Q2 2013.
  • 97 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2021.

Based on AQR Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.